Abstract:Although the risk difference (RD) is the most common and well explored functional form for testing efficacy with dichotomous endpoint, odds ratio (OR) is also suggested and well applied measure for non-inferiority (NI) trials. Since the construction and interpretation of these function forms are quite different, this study aims to provide detailed discussions and comprehensive comparisons on the design and testing approach for RD and OR scales for the fixed and group sequential three-arm NI trials under various of situations. The sample size determinations and testing approaches for assessing NI of a new treatment in three-arm clinical trials for RD and OR scales were reviewed comprehensively. Simulation studies are conducted for hundreds of scenarios with parameter configurations of the response rates, randomized allocations, NI margins and interim analysis. The operating characteristic (OC) of RD and OR scales based on the MLE and RMLE methods were thoroughly investigated. A trial example was designed and analyzed to demonstrate the methodologies. It is found that sample size determination on OR scale gives smaller sample size and robust procedure compared to RD scale in the majority of situations. When evaluating the behaviors of the attained power, the RMLE methods based on OR scale outperforms the MLE method and tend to have more power to reject the null hypothesis especially under the small sample size situations. Compared to the fixed design, the group sequential design has better OC, which provides a comparable power while needing smaller total average sample sizes for all cases. In addition, we suggest a lower significance level with a higher power for the sample size determination in the superiority test stage in the group sequential design, which can significantly reduce the total sample sizes while the number of subjects in the placebo group does not increase much. It can offer some recommendations for the investigators to choose the optimal endpoints and parameter configurations to design a three-arm NI trial under certain situations.

On Tests of Equivalence Via Non‐unity Relative Risk for Matched‐pair Design

Tests for equivalence based on odds ratio for matched-pair design

Non-parametric Tests for the Tail Equivalence Via Empirical Likelihood

Unconditional Exact Tests for Equivalence or Noninferiority for Paired Binary Endpoints

Wald tests for variance-adjusted equivalence assessment with normal endpoints

Equivalence tests for binary efficacy-toxicity responses

An efficient asymptotic approach for testing monotone proportions assuming an underlying logit based order dose-response model

Testing Equality of Treatments under an Incomplete Block Crossover Design with Ordinal Responses

A Comparative Review of Methods for Comparing Means Using Partially Paired Data

Testing Biased Randomization Assumptions and Quantifying Imperfect Matching and Residual Confounding in Matched Observational Studies

Multiple tests for restricted mean time lost with competing risks data

Relative likelihood ratios for neutral comparisons of statistical tests in simulation studies

Homogeneity tests and interval estimations of risk differences for stratified bilateral and unilateral correlated data

Combined Tests Based on Restricted Mean Time Lost for Competing Risks Data

A nonparametric relative treatment effect for direct comparisons of censored paired survival outcomes

Robust tests for treatment comparisons based on recurrent event responses

Approximative Tests for the Equality of Two Cumulative Incidence Functions of a Competing Risk

Nonparametric tests for transition probabilities in nonhomogeneous Markov processes

Bridging the Gap Between Design and Analysis: Randomization Inference and Sensitivity Analysis for Matched Observational Studies with Treatment Doses

Optimization the Design of Fixed and Group Sequential Three-Arm Non-Inferiority Trials with Dichotomous Endpoints of Risk Difference and Odds Ratio

Risk difference tests for stratified binary data under Dallal's model